Filter by: patients
What is Symlin?

Symlin® is a brand name of pramlintide, an antidiabetic agent. It is an injectable medicine used to control blood sugar after meals in adults with type 2 and type 1 diabetes who take mealtime insulin.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Other 1 0
improve post-prandial blood sugars 1 0
help the body realize it is full by simulating Amylin 1 0
Diabetes Type 1 1 0

See 1 patient currently taking Symlin

Mouse over the table for more information

Reported Dosages

  20 daily
  1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Symlin (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 1   Doctor's advice: 100%
Side effects too severe 1   Side effects too severe: 100%
Other 1   Other: 100%

See all 1 patient who’ve stopped taking Symlin

Stopped Taking Symlin

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.